These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27040016)

  • 1. Severe hypoglycaemia in elderly patients with type 2 diabetes and coexistence of cardiovascular history.
    Piątkiewicz P; Buraczewska-Leszczyńska B; Kuczerowski R; Bernat-Karpińska M; Rabijewski M; Kowrach M
    Kardiol Pol; 2016; 74(8):779-785. PubMed ID: 27040016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
    Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
    Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older.
    Greco D; Angileri G
    Diabetes Nutr Metab; 2004 Feb; 17(1):23-6. PubMed ID: 15163121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with diabetes requiring emergency department care for hypoglycaemia: characteristics and long-term outcomes determined from multiple data sources.
    Rajendran R; Hodgkinson D; Rayman G
    Postgrad Med J; 2015 Feb; 91(1072):65-71. PubMed ID: 25595126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
    Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
    Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.
    Holstein A; Plaschke A; Egberts EH
    Diabetes Metab Res Rev; 2001; 17(6):467-73. PubMed ID: 11757083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis.
    Schopman JE; Simon AC; Hoefnagel SJ; Hoekstra JB; Scholten RJ; Holleman F
    Diabetes Metab Res Rev; 2014 Jan; 30(1):11-22. PubMed ID: 24030920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy and safety of linagliptin in elderly patients with type 2 diabetes: a pooled analysis of eight placebo-controlled clinical trials].
    Guo XH; Feng ZK; Xu LH
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):588-594. PubMed ID: 28789492
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study.
    Zaccardi F; Ling S; Lawson C; Davies MJ; Khunti K
    Diabetologia; 2020 Oct; 63(10):2129-2139. PubMed ID: 32728893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
    Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
    Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes.
    He Y; Kunutsor SK; Kingsnorth AP; Gillies C; Choudhary P; Khunti K; Zaccardi F
    Diabetes Obes Metab; 2024 Aug; 26(8):3361-3370. PubMed ID: 38826105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes.
    Home PD; Bolli GB; Mathieu C; Deerochanawong C; Landgraf W; Candelas C; Pilorget V; Dain MP; Riddle MC
    Diabetes Obes Metab; 2015 Jan; 17(1):15-22. PubMed ID: 24957785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study.
    Müller N; Khunti K; Kuss O; Lindblad U; Nolan JJ; Rutten GE; Trento M; Porta M; Roth J; Charpentier G; Jörgens V; Müller UA
    Acta Diabetol; 2017 Feb; 54(2):209-214. PubMed ID: 27837286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.
    Liatis S; Mylona M; Kalopita S; Papazafiropoulou A; Karamagkiolis S; Melidonis A; Xilomenos A; Ioannidis I; Kaltsas G; Lanaras L; Papas S; Basagiannis C; Kokkinos A
    Diabetes Metab; 2015 Apr; 41(2):126-31. PubMed ID: 25468446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal patterns of hypoglycaemia and burden of sulfonylurea-related hypoglycaemia in UK hospitals: a retrospective multicentre audit of hospitalised patients with diabetes.
    Rajendran R; Kerry C; Rayman G;
    BMJ Open; 2014 Jul; 4(7):e005165. PubMed ID: 25009134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of risk of hypoglycaemia during addition and titration of insulin glargine for type 2 diabetes mellitus.
    Karl DM; Gill J; Zhou R; Riddle MC
    Diabetes Obes Metab; 2013 Jul; 15(7):622-8. PubMed ID: 23350795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
    Miller ME; Bonds DE; Gerstein HC; Seaquist ER; Bergenstal RM; Calles-Escandon J; Childress RD; Craven TE; Cuddihy RM; Dailey G; Feinglos MN; Ismail-Beigi F; Largay JF; O'Connor PJ; Paul T; Savage PJ; Schubart UK; Sood A; Genuth S;
    BMJ; 2010 Jan; 340():b5444. PubMed ID: 20061360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial.
    Gallwitz B; Rosenstock J; Patel S; von Eynatten M; Hehnke U; Mehlburger L; Dugi KA; Woerle HJ
    Diabetes Obes Metab; 2015 Mar; 17(3):276-84. PubMed ID: 25425502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).
    Dungan KM; Weitgasser R; Perez Manghi F; Pintilei E; Fahrbach JL; Jiang HH; Shell J; Robertson KE
    Diabetes Obes Metab; 2016 May; 18(5):475-82. PubMed ID: 26799540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.